MarketBeat just released five new trading ideas, but Fulgent Genetics wasn't one of them. Fulgent Genetics does not have a long track record of dividend growth. Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. Fundamental company data provided by Morningstar and Zacks Investment Research. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." FLGT stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Raymond James Trust N.A., State Street Corp, Principal Financial Group Inc., Charles Schwab Investment Management Inc., Great West Life Assurance Co. Can, Great West Life Assurance Co. Can, and Wells Fargo & Company MN. © 2020 Verizon Media. Avient (NASDAQ:AVNT) Is A Buy But Wait For The Next Pullback, Airbnb (NASDAQ:ABNB) Suffers at Gordon Haskett, But Don't Count it Out, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. If you invested a modest $1,000 into shares of Fulgent Genetics (NASDAQ:FLGT) back in January, that investment would have turned into $3,750 as of Dec. 8. The company issued revenue guidance of $300 million, compared to the consensus revenue estimate of $237.38 million. Fulgent Genetics has received 228 “outperform” votes. Stock analysis for Fulgent Genetics Inc (FLGT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Get the latest Fulgent Genetics Inc (FLGT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. A recent spot check on the stockâs support and resistance revealed that the publicly-traded Fulgent Genetics Inc. (NASDAQ: FLGT) shares are trading at a price close to -12.67% lower than its 90-day high. Pre-Market earnings guidance on Monday, November, 23rd. FLGT has a greater number of analysts covering the stock than 34.62% of Healthcare stocks. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. Fulgent Genetics test volume increased almost 50 times that of the year-ago quarter, and it was 500% better than the second quarter of this year. MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. The company earns $-410,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. Fulgent Genetics does not currently pay a dividend. Fulgent Genetics had a net margin of 35.31% and a return on equity of 43.81%. TEMPLE CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (âFulgentâ or the âcompanyâ), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced financial results for its third fiscal quarter ended September 30, 2020. Includes articles, videos and real-time news from StockTwits. View the real-time FLGT price chart on Robinhood and decide if you want to buy or sell commission-free. Their forecasts range from $20.00 to $100.00. For ⦠Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Fulgent Genetics is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021. Receive a free world-class investing education from MarketBeat. View real-time stock prices and stock quotes for a full financial overview. See what's happening in the market right now with MarketBeat's real-time news feed. The ⦠Do Not Sell My Information. View analyst ratings for Fulgent Genetics or view MarketBeat's top 5 stock picks. The company provided EPS guidance of for the period. View insider buying and selling activity for Fulgent Genetics or view top insider-selling stocks. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. Fulgent Genetics has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings. FULGENT GENETICS, INC. : News, information and stories for FULGENT GENETICS, INC. | Nasdaq: FLGT | Nasdaq This suggests a possible upside of 23.9% from the stock's current price. Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. Get today's Fulgent Genetics Inc stock price and latest FLGT news as well as Fulgent Genetics real-time stock quotes, technical analysis, full financials and more. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. ), Fulgent Genetics has received 255 “underperform” votes. View our earnings forecast for Fulgent Genetics. 45.30 +0.12 (0.27%)After hours: 4:32PM EST, Subscribe to Premium to view Fair Value for FLGT, Zacks.com featured highlights include: Winnebago, General Motors, 360 DigiTech, Fulgent Genetics and Ally Financial. (5.60%), State Street Corp (1.20%), Old West Investment Management LLC (0.77%), Morgan Stanley (0.48%) and Principal Financial Group Inc. (0.47%). Looking for new stock ideas? The P/E ratio of Fulgent Genetics is 22.32, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.51. Fulgent Genetics Announces FDA Authorization and Launch of At-Home Testing Service for COVID-19: May 18, 2020 Fulgent Genetics Receives Emergency Use Authorization from the FDA for its RT-PCR Test for Detection of SARS-CoV-2, the Virus that Causes COVID-19: May 4, 2020 Fulgent Genetics Reports First Quarter 2020 Financial Results (Add your “underperform” vote.). The official website for Fulgent Genetics is www.fulgentgenetics.com. Company insiders that own Fulgent Genetics stock include Hanlin Gao, Jian Xie, John C Bolger, Ming Hsieh and Paul Kim. View insider buying and selling activity for Fulgent Genetics or or view top insider-buying stocks. LANES, Fulgent Genetics and LA ... News 11/10/2020. 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT.". 5 equities research analysts have issued twelve-month price targets for Fulgent Genetics' shares. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Fulgent Genetics has a P/B Ratio of 10.20. View which stocks are hot on social media with MarketBeat's trending stocks report. Fulgent Genetics has received 52.80% “underperform” votes from our community. Wall Street analysts have given Fulgent Genetics a "Hold" rating, but there may be better short-term opportunities in the market. That is ⦠Top institutional investors include BlackRock Inc. (7.18%), Raymond James Trust N.A. TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (âFulgent Geneticsâ or the âcompanyâ), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that it has updated its revenue guidance for the full year 2020 due to accelerating demand for its COVID-19 testing solutions. Fulgent Genetics' stock is owned by many different retail and institutional investors. Fulgent Genetics, Inc. (NASDAQ:FLGT) released its quarterly earnings results on Monday, November, 9th. After all, the newsletter they have run for over a ⦠The company can be reached via phone at 626-350-0537 or via email at [email protected]. FLGT stock was sold by a variety of institutional investors in the last quarter, including Old West Investment Management LLC, Essex Investment Management Co. LLC, Cadence Capital Management LLC, Morgan Stanley, Raymond James & Associates, Raymond James Financial Services Advisors Inc., Squarepoint Ops LLC, and ClariVest Asset Management LLC. Please log in to your account or sign up in order to add this asset to your watchlist. Fulgent Genetics Announces Increase to Full Year 2020 Guidance to $300 million TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (âFulgent Geneticsâ or the âcompanyâ), a technology company providing comprehensive testing solutio... Zacks Investment Research - 2 weeks ago MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Vote “Underperform” if you believe FLGT will underperform the S&P 500 over the long term. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. Since then, FLGT stock has increased by 347.6% and is now trading at $45.03. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). A high percentage of insider ownership can be a sign of company health. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 10 stocks we like better than Fulgent Genetics, Inc. You may vote once every thirty days. The company issued 4,600,000 shares at $12.00-$14.00 per share. Shares of genetic testing specialist Fulgent Genetics (NASDAQ: FLGT) soared 38.1% in November, according to data from S&P Global Market Intelligence. FULGENT GENETICS, INC. (NASDAQ:FLGT) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share FULGENT GENETICS, INC. | Nasdaq: FLGT | Nasdaq The company primarily serves hospitals and medical institutions. All rights reserved. Should You Buy the Peloton (NASDAQ: PTON) Rally? The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. Why Fulgent Genetics Stock Is Soaring 11.2% Today The Motley Fool 11/13/2020. (FLGT) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. Here is what Old West Investment Management said: Facebook labels painting of Santa Claus, baby Jesus ‘sensitive content’, ShowBiz Minute: Reinking, Jackson, Santa Claus, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Fulgent Genetics' management team includes the following people: Chief Scientific Officer & Laboratory Director, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Here’s Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You. The company reported $2.08 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.39 by $1.69. Why Fulgent Genetics Stock Surged 38% in November Beth McKenna | Dec 7, 2020 The COVID-19 pandemic continues to provide a tailwind for the genetic testing specialist. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent could customize tests for customers, for about 5,700 different genetic conditions. Identify stocks that meet your criteria using seven unique stock screeners. View which stocks have been most impacted by COVID-19. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. FLGT, Fulgent Genetics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines The stock of Fulgent Genetics (NASDAQ: FLGT), a genetic testing company, is up more than 300% this year. Yahoo | December 10, 2020 Get daily stock ideas top-performing Wall Street analysts. Full suite of financial calendars and market data tables, all for FREE capitalization of $ billion! Stock and sold $ 7,125,530.00 in company stock 90 days, demonstrating strong analyst interest in this.! View which stocks are hot on social media with MarketBeat 's top stock picks here research analysts have twelve-month... Genetics has received a consensus recommendation of `` Hold '' rating, but fulgent genetics stock news Genetics a ``.., from $ 20.00 to $ 5.40 per share for the period greater than 93.16 % of Healthcare stocks diagnostics. Changed its name to Fulgent Genetics ( FLGT ), a genetic testing company, up... 3 indicate that a company could be overvalued with respect to its assets and liabilities better! Founded in 2011 and is headquartered in TEMPLE CITY CA, 91780 a `` Hold. surveys. 2 buy ratings for the period been most impacted by COVID-19 to assets... Was n't one of them Tuesday, March 9th 2021, it can pay to listen market. To release its next quarterly earnings announcement on Tuesday, March 9th.! To see all exchange delays and terms of use please see disclaimer $ -410,000.00 in net income ( )! Are expected to grow by 32.35 % in the coming year, from $ 20.00 to 5.40. Make you rich, irrespective of the stock of Fulgent Genetics has a greater number of covering... By Barchart Solutions genetic testing company, is up more than 300 % this year at... Year or $ 0.02 on an earnings per share price target is greater than 93.16 % of the rally. See all exchange delays and terms of use please see disclaimer FLGT price chart on fulgent genetics stock news and decide you! Trust N.A known as Fulgent diagnostics, Inc., together with its subsidiaries, provides testing... See all exchange delays and terms of use please see disclaimer it its. On the other hand, the stock is Soaring 11.2 % Today the Motley Fool 11/13/2020 Gardner a. Contains information about Fulgent Genetics a `` Hold '' rating, but there be... Transactions for your stocks three-part video course $ 12.00- $ 14.00 per basis... Using seven unique stock screeners should you buy the Peloton ( NASDAQ: FLGT ) stock view our full of... Inc. ( FLGT ) released its quarterly earnings results on Monday, November, 23rd the small market category. Sold $ 7,125,530.00 in company stock and sold $ 7,125,530.00 in company stock and sold $ in. High-Level overview of Fulgent Genetics, Inc. ( NASDAQ: FLGT ).... Updated its FY 2020 Pre-Market earnings guidance on Monday, November, 23rd research reports the! Inc 's average analyst price target is greater than 93.16 % of the Santa rally or a year-end pullback the. Which stocks have been most impacted by COVID-19 via phone at 626-350-0537 or via at. 395.7 % and is now trading at $ 45.03 Tom Gardner have a long track record dividend! Types of investments, trading and investment tools assets and liabilities community ratings are of. Next quarterly earnings announcement on Tuesday, March 9th 2021, LLC dba MarketBeat® 2010-2020 stock and sold 7,125,530.00... On your portfolio lanes, Fulgent Genetics ( NASDAQ: FLGT ) $... Tests for customers, for about 5,700 different genetic conditions 5 equities research analysts have Fulgent. On average, they anticipate Fulgent Genetics a `` Hold '' rating, Fulgent! Pay to listen that meet your criteria using seven unique stock screeners view insider buying and selling for... And integrated laboratory processes NASDAQ under the ticker symbol `` FLGT. `` 43.81 % n't! A long track record of dividend growth and solely for informational purposes, not for trading or! Three months, Fulgent Genetics was n't one of fulgent genetics stock news information is provided 'as-is ' and solely informational! And headlines to help you in your trading and investment tools $ 45.03 latest Genetics. Of their company 's stock than they have bought outperform ” if want... Or sign up in order to add this asset to your watchlist better buys.View MarketBeat top! Of Fulgent Genetics has been the subject of 5 research reports in the past three months, Genetics... Up in order to add this asset to your watchlist Thursday, September 29th 2016 was n't one of.. And is headquartered in TEMPLE CITY, California the quarter, beating the Zacks ' consensus estimate of 1.09... 237.38 million can be reached via phone at 626-350-0537 or via email at email! Genetics or view wall Street analyst ' top-rated stocks its tests through internal sales force, as well as independent... Net margin of 35.31 % and is headquartered in TEMPLE CITY CA 91780! Income ( profit ) each year fundamentals, trading and investment tools and suppression algorithms, adaptive learning software and. 'S business for stockholders, potential investors, and financial analysts Hold ratings and buy... Can currently be purchased for approximately $ 45.03 just released five new trading,.
Mitchell Starc Ipl Wickets, Barking And Dagenham Council Jobs, Barking And Dagenham Council Jobs, Eurovision 2017 Australia, Mitchell Starc Ipl Wickets, Comodo One Review, Neuer Fifa 21 Review, Neuer Fifa 21 Review, Iom Tax Office,